Traumatic Hemothorax Drainage and Daily Lavage

NCT06937450 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-05-05

No results posted yet for this study

Summary

This HTX treatment study evaluates the effects of chest tube size and the benefits of daily irrigations on acute HTX. 20 acutely injured but stable trauma patients requiring a chest tube for HTX will be enrolled. Patients will be assigned a 28Fr or 14 Fr chest tube with serial lavage and drainage. The endpoints will be HTX volume (by CT scan), complications, additional interventions, hospital length of stay, chest tube duration, provider feedback, and patient-reported outcomes.

Conditions

  • Hemothorax; Traumatic

Interventions

DEVICE

CLR Irrigator

All enrolled patients will have their hemothorax treated with a CLR device that allows for easy suction and irrigation through indwelling catheters,

PROCEDURE

Serial Lavage and Drainage

The current protocol is to do a singular lavage and drainage, this study will investigate the benefits of daily lavage.

DEVICE

28 Fr Open Chest Tube

Patients will have a standard 28 Fr open chest tube or a percutaneous 14Fr chest tube placed.

DEVICE

Percutaneous 14Fr Chest Tube

Patients will have a standard 28 Fr open chest tube, or a percutaneous 14Fr chest tube placed.

Sponsors & Collaborators

Principal Investigators

  • Jeremy Cannon, MD · University of Pennsylvania

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-03
Primary Completion
2026-08-01
Completion
2027-08-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06937450 on ClinicalTrials.gov